Treat patients like Alison and Sean with LUTATHERA ASAP
.
Alison has been newly diagnosed with NETs after 3 years of navigating symptoms.
Because of her aggressive disease, Alison and her doctor chose to start strong with 1L LUTATHERA
*SSTR+ with Karnofsky PS of 90.1
†Grade 2 is defined as a Ki-67 index of 3% to 20%.1
Sean received a NET diagnosis 2 years ago. He started initial treatment with SSA therapy but recently started progressing and is looking for the right next step.
Immediately after SSA progression,‡ Sean and his doctor decided on 2L LUTATHERA
*SSTR+ with Karnofsky PS of 90.1
†Grade 1 is defined as a Ki-67 index <3%.1
‡After multiple progression events, eligibility for LUTATHERA may become limited.
†Grade 1 is defined as a Ki-67 index <3%.1
‡After multiple progression events, eligibility for LUTATHERA may become limited.
1L, first line; 2L, second line; NETs, neuroendocrine tumors; PS, performance score; SSA, somatostatin analogue; SSTR+, somatostatin receptor-positive.